Allergy Therapeutics PLC Notice of Preliminary Results (8890I)
September 05 2016 - 2:00AM
UK Regulatory
TIDMAGY
RNS Number : 8890I
Allergy Therapeutics PLC
05 September 2016
5 September 2016
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Notice of Preliminary Results
Allergy Therapeutics (AIM:AGY), the fully integrated specialty
pharmaceutical company specialising in allergy vaccines, will issue
its preliminary results for the twelve-month period ended 30 June
2016 on Monday 26 September 2016.
Manuel Llobet, Chief Executive Officer, and Nick Wykeman,
Finance Director, will host a presentation and conference call for
analysts on the day of results at the offices of Panmure Gordon,
One New Change, London, EC4M 9AF.
- ENDS -
For further information, please contact:
Allergy Therapeutics
+44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer
Nick Wykeman, Finance Director
Panmure Gordon
+44 (0) 20 7886 2500
Freddy Crossley / Duncan Monteith, Corporate Finance
Tom Salvesen, Corporate Broking
Consilium Strategic Communications
+44 20 3709 5700
Mary-Jane Elliott / Ivar Milligan / Matthew Neal / Laura
Thornton
allergytherapeutics@consilium-comms.com
Note to editors:
About Allergy Therapeutics
Allergy Therapeutics is an international specialty
pharmaceutical company focussed on the treatment and diagnosis of
allergic disorders including immunotherapy vaccines that cure
disease. The Company sells proprietary products and third party
products from its subsidiaries in nine major European countries and
via distribution agreements in an additional ten countries.
Formed in 1999 out of Smith Kline Beecham, Allergy Therapeutics
is headquartered in Worthing, UK with MHRA-approved manufacturing
facilities. The Company employs c.420 employees and is listed on
the London Stock Exchange (AIM:AGY). For more information, please
see www.allergytherapeutics.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOREAFNLEDKKEAF
(END) Dow Jones Newswires
September 05, 2016 02:00 ET (06:00 GMT)
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024